Mayank Mamtani
Stock Analyst at B. Riley Securities
(3.80)
# 1,923
Out of 4,402 analysts
1098
Total ratings
38%
Success rate
4.7%
Average return
Main Sectors:
Stocks Rated by Mayank Mamtani
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELTX Elicio Therapeutics | Initiated Coverage: Buy | $27 | $14.70 | +83.67% | 1 | Jun 10, 2026 | |
| AAPG Ascentage Pharma Group International | Initiated Coverage: Buy | $45 | $17.50 | +157.14% | 1 | Jun 10, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $45 | $31.21 | +44.21% | 6 | May 29, 2026 | |
| MGNX MacroGenics | Maintained: Buy | $9 | $4.10 | +119.51% | 9 | May 22, 2026 | |
| NUVB Nuvation Bio | Maintained: Buy | $12 | $5.16 | +132.78% | 3 | May 21, 2026 | |
| HROW Harrow | Maintained: Buy | $65 → $60 | $39.54 | +51.75% | 29 | May 14, 2026 | |
| UNCY Unicycive Therapeutics | Initiated Coverage: Buy | $22 | $7.81 | +181.69% | 1 | May 1, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $40 | $23.35 | +71.31% | 3 | Apr 10, 2026 | |
| NVAX Novavax | Maintained: Buy | $16 → $18 | $9.12 | +97.37% | 118 | Apr 9, 2026 | |
| TBPH Theravance Biopharma | Maintained: Hold | $14 → $17 | $16.62 | +2.29% | 3 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $1.13 | +165.49% | 16 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $42 → $45 | $39.71 | +13.32% | 7 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $6.30 | +90.48% | 2 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $4 | $1.29 | +211.28% | 17 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $11.18 | +132.56% | 1 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $7.04 | +212.50% | 25 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $22.11 | +35.69% | 25 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 | $70.45 | +53.30% | 23 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $150 | $60.58 | +147.61% | 9 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $117 | $85.76 | +36.44% | 3 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $8.24 | +240.01% | 3 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $33 | $18.06 | +82.72% | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 → $55 | $49.60 | +10.89% | 65 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $2.15 | +830.23% | 1 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $12.28 | +250.16% | 5 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $16 | $14.18 | +12.83% | 22 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $18 | $2.64 | +581.82% | 71 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 | $29.17 | +191.40% | 34 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $3.44 | +132.56% | 82 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $74.82 | n/a | 78 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $422 → $460 | $479.71 | n/a | 57 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.5 → $2 | $0.56999999 | n/a | 35 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.5 → $2 | $1.22 | n/a | 23 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $32.00 | n/a | 1 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.77 | n/a | 30 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.765 | n/a | 15 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.08 | n/a | 16 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $140 | $8.74 | n/a | 4 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $4 | $3.95 | n/a | 25 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.31 | n/a | 23 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0111 | n/a | 10 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.66 | n/a | 16 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 14 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.29 | n/a | 14 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.70 | n/a | 8 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.25 | n/a | 14 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.07 | n/a | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $120 | $13.58 | n/a | 7 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $10 | $12.25 | n/a | 14 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $27.03 | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.29 | n/a | 26 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.001 | n/a | 7 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.32 | n/a | 19 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.73 | n/a | 7 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.61 | n/a | 11 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.29 | n/a | 10 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 18 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.21 | n/a | 4 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $28.61 | n/a | 1 | May 12, 2020 |
Elicio Therapeutics
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $14.70
Upside: +83.67%
Ascentage Pharma Group International
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $17.50
Upside: +157.14%
ArriVent BioPharma
May 29, 2026
Maintained: Buy
Price Target: $45
Current: $31.21
Upside: +44.21%
MacroGenics
May 22, 2026
Maintained: Buy
Price Target: $9
Current: $4.10
Upside: +119.51%
Nuvation Bio
May 21, 2026
Maintained: Buy
Price Target: $12
Current: $5.16
Upside: +132.78%
Harrow
May 14, 2026
Maintained: Buy
Price Target: $65 → $60
Current: $39.54
Upside: +51.75%
Unicycive Therapeutics
May 1, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $7.81
Upside: +181.69%
Zymeworks
Apr 10, 2026
Reiterated: Buy
Price Target: $40
Current: $23.35
Upside: +71.31%
Novavax
Apr 9, 2026
Maintained: Buy
Price Target: $16 → $18
Current: $9.12
Upside: +97.37%
Theravance Biopharma
Apr 7, 2026
Maintained: Hold
Price Target: $14 → $17
Current: $16.62
Upside: +2.29%
Apr 7, 2026
Maintained: Buy
Price Target: $3
Current: $1.13
Upside: +165.49%
Mar 31, 2026
Downgraded: Hold
Price Target: $42 → $45
Current: $39.71
Upside: +13.32%
Mar 26, 2026
Rated: Buy
Price Target: $12
Current: $6.30
Upside: +90.48%
Mar 25, 2026
Maintained: Buy
Price Target: $3 → $4
Current: $1.29
Upside: +211.28%
Mar 24, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $11.18
Upside: +132.56%
Mar 18, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $7.04
Upside: +212.50%
Mar 13, 2026
Reiterated: Buy
Price Target: $30
Current: $22.11
Upside: +35.69%
Mar 10, 2026
Reiterated: Buy
Price Target: $108
Current: $70.45
Upside: +53.30%
Feb 23, 2026
Maintained: Buy
Price Target: $105 → $150
Current: $60.58
Upside: +147.61%
Dec 22, 2025
Maintained: Buy
Price Target: $80 → $117
Current: $85.76
Upside: +36.44%
Oct 6, 2025
Reiterated: Buy
Price Target: $28
Current: $8.24
Upside: +240.01%
Oct 3, 2025
Maintained: Buy
Price Target: $29 → $33
Current: $18.06
Upside: +82.72%
Sep 17, 2025
Maintained: Buy
Price Target: $53 → $55
Current: $49.60
Upside: +10.89%
Aug 26, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $2.15
Upside: +830.23%
Aug 19, 2025
Maintained: Buy
Price Target: $43
Current: $12.28
Upside: +250.16%
Aug 14, 2025
Maintained: Buy
Price Target: $20 → $16
Current: $14.18
Upside: +12.83%
Aug 13, 2025
Maintained: Buy
Price Target: $20 → $18
Current: $2.64
Upside: +581.82%
Jul 15, 2025
Maintained: Buy
Price Target: $85
Current: $29.17
Upside: +191.40%
Jul 1, 2025
Maintained: Buy
Price Target: $8
Current: $3.44
Upside: +132.56%
May 14, 2025
Maintained: Buy
Price Target: $38
Current: $74.82
Upside: n/a
May 2, 2025
Maintained: Buy
Price Target: $422 → $460
Current: $479.71
Upside: n/a
Mar 27, 2025
Maintained: Buy
Price Target: $2.5 → $2
Current: $0.56999999
Upside: n/a
Feb 6, 2025
Maintained: Buy
Price Target: $1.5 → $2
Current: $1.22
Upside: n/a
Jan 9, 2025
Initiated Coverage: Buy
Price Target: $21
Current: $32.00
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $2.77
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $0.765
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $1.08
Upside: n/a
Jun 14, 2024
Reiterated: Buy
Price Target: $4 → $140
Current: $8.74
Upside: n/a
May 17, 2023
Reiterated: Buy
Price Target: $3 → $4
Current: $3.95
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $1.31
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.0111
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $1.66
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.29
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.70
Upside: n/a
Dec 15, 2022
Maintained: Buy
Price Target: $6
Current: $1.25
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $2.07
Upside: n/a
Mar 31, 2022
Maintained: Buy
Price Target: $3 → $120
Current: $13.58
Upside: n/a
Mar 23, 2022
Maintained: Buy
Price Target: $17 → $10
Current: $12.25
Upside: n/a
Nov 12, 2021
Maintained: Buy
Price Target: $67
Current: $27.03
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $4.29
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $0.001
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $14.32
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $2.73
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $0.61
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $2.29
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $9.21
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $28.61
Upside: n/a